Protalix BioTherapeutics, Inc. logo

Protalix BioTherapeutics, Inc.

1006281

Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with their ProCellEx® plant cell-based expression system. They focus on treating rare diseases and have already launched two enzyme replacement therapies. The company is known for its innovative ProCellEx® technology.

71
Pålitlig
Förtroendepoäng

Officiellt Register

Juridiskt Namn
Protalix BioTherapeutics, Inc.
Organisationsnummer
0001006281
Företagsstatus
Active
Branschkoder
2836: Biological Products, (No Diagnostic Substances)

Senast verifierad: 12/30/2025

AI Kvalitetsanalys

Bransch
Biotechnology
SSL/HTTPS
Säker
Professionell E-post
Nej

Förtroendepoäng Detaljer

Register Verifierat35/35
Kvalitetspoäng36/60
Nyhetsanalys0/5

Snabblänkar

Senast uppdaterad: 12/30/2025

🌟 Liknande Pålitliga Företag

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. logo
80/100 · Mycket Pålitlig

Cidara Therapeutics develops targeted immunotherapies to save lives and improve the standard of care for patients facing serious diseases. Their Cloudbreak platform creates “single molecule cocktails” designed to inhibit specific disease targets while engaging the immune system. Noted as a Top Place to Work for six years.

USA
Visa profil

Alpha Teknova, Inc.

Alpha Teknova, Inc. logo
74/100 · Pålitlig

This company provides a range of solutions and products, mainly focused on AAV (Adeno-Associated Virus) technologies, including PCR sample preparation kits, stabilizers, and AEX buffer screening kits. They also offer a variety of agar plates, bacterial and fungal culture media, buffers, reagents, and cryopreservation media for biological research. Their products are utilized in molecular biology, cell culture, and related scientific fields. They offer RUO and GMP grade products.

USA
Visa profil

RIGEL PHARMACEUTICALS INC

RIGEL PHARMACEUTICALS INC logo
79/100 · Pålitlig

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Key products include TAVALISSE and REZLIDHIA. The company is positioned as an innovator in hematology and oncology.

USA
Visa profil